Trinity Biotech (TRIB) Interest Expenses (2016 - 2024)
Historic Interest Expenses for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to -$3.4 million.
- Trinity Biotech's Interest Expenses fell 4467.27% to -$3.4 million in Q4 2024 from the same period last year, while for Jun 2025 it was -$9.3 million, marking a year-over-year decrease of 20495.08%. This contributed to the annual value of $9.6 million for FY2024, which is 1346.24% down from last year.
- According to the latest figures from Q4 2024, Trinity Biotech's Interest Expenses is -$3.4 million, which was down 4467.27% from -$3.1 million recorded in Q3 2024.
- Over the past 5 years, Trinity Biotech's Interest Expenses peaked at $2.4 million during Q4 2022, and registered a low of -$12.2 million during Q1 2022.
- For the 5-year period, Trinity Biotech's Interest Expenses averaged around -$2.0 million, with its median value being -$1.4 million (2021).
- Examining YoY changes over the last 5 years, Trinity Biotech's Interest Expenses showed a top increase of 20929.49% in 2023 and a maximum decrease of 4616024.1% in 2023.
- Over the past 5 years, Trinity Biotech's Interest Expenses (Quarter) stood at -$1.2 million in 2020, then tumbled by 145.18% to -$3.0 million in 2021, then surged by 179.81% to $2.4 million in 2022, then crashed by 197.58% to -$2.3 million in 2023, then tumbled by 44.67% to -$3.4 million in 2024.
- Its Interest Expenses was -$3.4 million in Q4 2024, compared to -$3.1 million in Q3 2024 and -$2.8 million in Q2 2024.